novo tirzepatide Eli Lilly launches weight-loss drug Mounjaro in India, beats Nordisk to major market Novo Nordisk filed a lawsuit

Oral and IV glutathione supplements may be unsafe for women who are pregnant or breastfeeding, people who take prescription or over-the-counter medications, and those who have chronic conditions

For years this category has existed in a gray zone where patient demand and clinical interest have far outpaced any formal regulatory review. As for how the general public feels about peptides, Koehl Robinson says she thinks the meetings are instrumental in shifting their view of the technology

Additionally, two-year safety data from the STEP 5 trial shows that while gastrointestinal events occurred in 82% of participants at some point during the study, most of these events were concentrated in the initial 6 months, with frequency and severity declining markedly in long-term treatment

Why protein comes first while losing weight, and practical ways to hit daily targets when your appetite is low

Graphical Abstract Similar content being viewed by others Introduction Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for approximately 17.9 million deaths annually, representing around 32% of all global deaths [1]